Drugs that contain Etelcalcetide

1. Drug name - PARSABIV

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US9278995 KAI PHARMS INC Therapeutic agents for reducing parathyroid hormone levels
Jul, 2030

(7 years from now)

US8377880 KAI PHARMS INC Therapeutic agents for reducing parathyroid hormone levels
Jul, 2030

(7 years from now)

US9701712 KAI PHARMS INC Therapeutic agents for reducing parathyroid hormone levels
Jul, 2030

(7 years from now)

US8999932 KAI PHARMS INC Therapeutic agents for reducing parathyroid hormone levels
Feb, 2031

(8 years from now)

CN102711789A KAI PHARMS INC Therapeutic Agents For Reducing Parathyroid Hormone Levels
Jul, 2030

(7 years from now)

CN102711789B KAI PHARMS INC Therapeutic Agents For Reducing Parathyroid Hormone Level
Jul, 2030

(7 years from now)

IN350519B KAI PHARMS INC Therapeutic Agents For Reducing Parathyroid Hormone Levels
Jul, 2030

(7 years from now)

IN201201196P1 KAI PHARMS INC Therapeutic Agents For Reducing Parathyroid Hormone Levels
Jul, 2030

(7 years from now)

EP3192520B1 KAI PHARMS INC Therapeutic Agents For Reducing Parathyroid Hormone Levels
Jul, 2030

(7 years from now)

EP3539555A1 KAI PHARMS INC Therapeutic Agents For Reducing Parathyroid Hormone Levels
Jul, 2030

(7 years from now)

EP3539555B1 KAI PHARMS INC Therapeutic Agents For Reducing Parathyroid Hormone Levels
Jul, 2030

(7 years from now)

EP3192520A1 KAI PHARMS INC Therapeutic Agents For Reducing Parathyroid Hormone Levels
Jul, 2030

(7 years from now)

EP2459208A4 KAI PHARMS INC Therapeutic Agents For Reducing Parathyroid Hormone Levels
Jul, 2030

(7 years from now)

EP2459208B1 KAI PHARMS INC Therapeutic Agents For Reducing Parathyroid Hormone Levels
Jul, 2030

(7 years from now)

EP2459208A2 KAI PHARMS INC Therapeutic Agents For Reducing Parathyroid Hormone Levels
Jul, 2030

(7 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11162500 KAI PHARMS INC Stable liquid formulation of AMG 416 (etelcalcetide) Jun, 2034

(11 years from now)

US9820938 KAI PHARMS INC Stable liquid formulation of AMG 416 (etelcalcetide) Jun, 2034

(11 years from now)

US10344765 KAI PHARMS INC Stable liquid formulation of AMG 416 (etelcalcetide) Jun, 2034

(11 years from now)

Treatment: NA

Dosage: SOLUTION;INTRAVENOUS

More Information on Dosage
Strength Dosage Availability
2.5MG/0.5ML (2.5MG/0.5ML) SOLUTION;INTRAVENOUS Prescription
5MG/ML (5MG/ML) SOLUTION;INTRAVENOUS Prescription
10MG/2ML (5MG/ML) SOLUTION;INTRAVENOUS Prescription

availability in other generic markets.

Click on the highlighted region to filter.